AVIVE INC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals are MORISHIGE FUKUMI, TOSHITSU KAGAKU KENKYUSHO KK and SANOFI SYNTHELABO OTC S P A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rajadas Jayakumar | 10 |
#2 | Serpooshan Vahid | 1 |
#3 | Ruiz-Lozano Pilar | 1 |
Publication | Filing date | Title |
---|---|---|
TW202045141A | Oral formulations of a biologically active peptide and uses thereof | |
US2019388348A1 | Compositions and methods for treating cardiovascular and pulmonary diseases with apelin | |
WO2018075822A1 | Novel pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases |